SG11201602019XA - Multigene assay for prognosis of renal cancer - Google Patents
Multigene assay for prognosis of renal cancerInfo
- Publication number
- SG11201602019XA SG11201602019XA SG11201602019XA SG11201602019XA SG11201602019XA SG 11201602019X A SG11201602019X A SG 11201602019XA SG 11201602019X A SG11201602019X A SG 11201602019XA SG 11201602019X A SG11201602019X A SG 11201602019XA SG 11201602019X A SG11201602019X A SG 11201602019XA
- Authority
- SG
- Singapore
- Prior art keywords
- prognosis
- renal cancer
- multigene assay
- multigene
- assay
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG11201602019XA SG11201602019XA (en) | 2013-09-17 | 2014-09-17 | Multigene assay for prognosis of renal cancer |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG2013070149 | 2013-09-17 | ||
PCT/SG2014/000446 WO2015050500A1 (en) | 2013-09-17 | 2014-09-17 | Multigene assay for prognosis of renal cancer |
SG11201602019XA SG11201602019XA (en) | 2013-09-17 | 2014-09-17 | Multigene assay for prognosis of renal cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201602019XA true SG11201602019XA (en) | 2016-04-28 |
Family
ID=52778982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201602019XA SG11201602019XA (en) | 2013-09-17 | 2014-09-17 | Multigene assay for prognosis of renal cancer |
Country Status (4)
Country | Link |
---|---|
US (1) | US11015190B2 (en) |
EP (1) | EP3047040B1 (en) |
SG (1) | SG11201602019XA (en) |
WO (1) | WO2015050500A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190127805A1 (en) * | 2016-03-15 | 2019-05-02 | Almac Diagnostics Limited | Gene signatures for cancer detection and treatment |
JP2019518970A (en) * | 2016-04-08 | 2019-07-04 | サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィック | Methods and kits for predicting sensitivity to cancer treatment of subjects suffering from kidney cancer |
KR102350603B1 (en) * | 2019-04-03 | 2022-01-14 | 고려대학교 산학협력단 | Composition for diagnosing or prognosing cancer including exosome based tuba1c proteins |
CN113430266A (en) * | 2021-06-25 | 2021-09-24 | 复旦大学附属肿瘤医院 | Application of G6PC and genome thereof in preparation of renal clear cell carcinoma diagnosis or prognosis evaluation system |
CN113444794B (en) * | 2021-06-25 | 2023-01-06 | 复旦大学附属肿瘤医院 | Application of combined genome in preparation of renal clear cell carcinoma prognosis evaluation system |
WO2023276869A1 (en) * | 2021-06-28 | 2023-01-05 | 学校法人 久留米大学 | Method for predicting prognosis after treatment with angiogenesis inhibitor, and combination therapy for cancer |
EP4361288A1 (en) * | 2022-10-25 | 2024-05-01 | Fundación Instituto de Investigación Sanitaria De Santiago de Compostela (FIDIS) | Personalized immunotherapy in renal carcinoma |
CN117187375A (en) * | 2023-09-12 | 2023-12-08 | 上海谱希和光基因科技有限公司 | Application of KDELR3 biomarker in diagnosis of high myopia |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005024603A2 (en) * | 2003-09-10 | 2005-03-17 | The Board Of Regents Of The University Of Texas System | Methods for detecting, diagnosing and treating human renal cell carcinoma |
US20080119367A1 (en) * | 2004-12-17 | 2008-05-22 | Mayo Foundation For Medical Education And Research | Prognosis of Renal Cell Carcinoma |
WO2008088861A2 (en) * | 2007-01-18 | 2008-07-24 | University Of Southern California | Gene polymorphisms predictive for dual tki therapy |
RU2010123381A (en) * | 2007-11-09 | 2011-12-20 | Дженентек, Инк. (Us) | METHOD AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS |
WO2010083252A2 (en) * | 2009-01-14 | 2010-07-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Ratio based biomarkers and methods of use thereof |
WO2011062634A2 (en) | 2009-11-18 | 2011-05-26 | Mannkind Corporation | Monoclonal antibodies and diagnostic uses thereof |
JP6286124B2 (en) * | 2010-01-11 | 2018-02-28 | ジェノミック ヘルス, インコーポレイテッド | A method to determine the likelihood of clinical outcome of renal cancer using gene expression |
-
2014
- 2014-09-17 SG SG11201602019XA patent/SG11201602019XA/en unknown
- 2014-09-17 EP EP14850441.8A patent/EP3047040B1/en active Active
- 2014-09-17 WO PCT/SG2014/000446 patent/WO2015050500A1/en active Application Filing
- 2014-09-17 US US15/022,917 patent/US11015190B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3047040A1 (en) | 2016-07-27 |
US20160230234A1 (en) | 2016-08-11 |
EP3047040B1 (en) | 2019-12-11 |
US11015190B2 (en) | 2021-05-25 |
EP3047040A4 (en) | 2017-07-12 |
WO2015050500A1 (en) | 2015-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285521A (en) | Assays for single molecule detection | |
HK1217218A1 (en) | Biomarkers for colorectal cancer | |
HK1219763A1 (en) | Compositions and methods for cancer prognosis | |
IL289514A (en) | Assays for determining plasma kallikrein system biomarkers | |
EP2825674A4 (en) | Thyroid cancer biomarker | |
SG11201602019XA (en) | Multigene assay for prognosis of renal cancer | |
EP3004374A4 (en) | Affinity-based detection of ligand-encoded synthetic biomarkers | |
DK3435084T3 (en) | PROSTATE CANCER PROGNOSIS USING BIOMARKERS | |
PL2726635T3 (en) | Multigene prognostic assay for lung cancer | |
EP2951592A4 (en) | Autoantibody signature for the early detection of ovarian cancer | |
EP2982985A4 (en) | System for predicting prognosis of locally advanced gastric cancer | |
IL276505B (en) | Predicting breast cancer recurrence | |
DK2914739T3 (en) | COMBINATIONS OF BIOMARKERS FOR COLORECTAL TUMORS | |
EP2986326A4 (en) | Methods for detecting cancer metastasis | |
HK1213634A1 (en) | Methods of detecting cancer | |
EP2977760A4 (en) | Biomarker for diagnosing liver cancer | |
EP3058101A4 (en) | Serum mirnas for the prognosis of prostate cancer | |
HK1224010A1 (en) | Biomarkers for ovarian cancer | |
EP3047277A4 (en) | Autoantibody biomarkers of ovarian cancer | |
EP2972376A4 (en) | Methods for determining prognosis of colorectal cancer | |
EP3047039A4 (en) | Inhibiting cancer metastasis | |
EP3015476A4 (en) | Tumor biomarker | |
GB201306339D0 (en) | Biomarkers for prognosis | |
EP3060914A4 (en) | Methods of determining breast cancer prognosis | |
EP3077549A4 (en) | Gene signatures for renal cancer prognosis |